RMC-035 is a small therapeutic protein, mimicking endogenous alpha-1-microglobulin (A1M), with a biodistribution profile and mechanism appropriate for targeting kidney injuries: reductase activity, free radical scavenging, haem binding, and mitochondrial binding/protection.10 This evidence concerns the gene AMBP and kidney injury.